Streetbeat News

Earnings

FSBC

Five Star (NASDAQ:FSBC) is expected to release its quarterly earnings report on Monday, 2024-01-29, with an estimated EPS of $0.59. Investors are looking for an earnings beat and positive guidance for the next quarter. Historically, the company's stock price has shown mixed reactions to past earnings performances. Currently, shares are trading at $25.4, down 2.58% over the last 52 weeks. The upcoming earnings report could influence the stock's performance, especially if the results differ from expectations or guidance is notably positive or negative.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

ARLP

Alliance Res Partners (NASDAQ:ARLP) is scheduled to release its quarterly earnings report on Monday, 2024-01-29, with an estimated EPS of $1.14. Investors are looking for an earnings beat and positive guidance for the next quarter. ARLP's stock performance has been negative over the last 52 weeks, with shares down 2.0%. The stock price reacted variably to past earnings performances, with minor changes following the EPS beats or misses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

GGG

Graco (NYSE:GGG) is expected to release its quarterly earnings report on Monday, 2024-01-29, with an estimated EPS of $0.79. Investors are looking for an earnings beat and positive guidance for future growth. Graco's stock performance has been positive over the last year, with shares up 27.02%, and past earnings beats have led to significant share price movements. The stock was trading at $84.57 as of January 25.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

HMST

HomeStreet (NASDAQ:HMST) is scheduled to release its quarterly earnings report on Monday, 2024-01-29, with analysts expecting an EPS of $0.02. Investors are looking for an earnings beat and positive guidance for future growth. HomeStreet's stock performance has been negative over the past year, with a 42.67% decline. The company's past earnings have shown mixed results, with both beats and misses, and varied stock price reactions.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

HTLF

Heartland Financial USA (NASDAQ:HTLF) is scheduled to release its quarterly earnings report on Monday, 2024-01-29, with an estimated EPS of $1.10. Investors are looking for an earnings beat and positive guidance for the next quarter. In the past, HTLF's stock price has been sensitive to earnings performance and guidance. Last quarter, the company missed EPS estimates by $0.01, resulting in a 5.19% share price drop. Over the last year, HTLF shares have declined by 17.98%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

DOW

Analysts have updated their ratings and price targets for Dow (NYSE:DOW), with recent actions including raises in ratings and price targets by Wells Fargo, B of A Securities, UBS, and Deutsche Bank. The average 12-month price target is now $58.2, up from $55.50. Dow's financials show a negative revenue trend with a -23.98% growth, but strong net margin, ROE, and ROA. The company's debt-to-equity ratio is below industry norms.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

TRNS

Transcat (NASDAQ:TRNS) is scheduled to release its latest quarterly earnings report on Monday, 2024-01-29, with analysts expecting an EPS of $0.35. Investors are looking for an earnings beat and positive guidance for the next quarter. Despite beating EPS estimates in the past four quarters, the stock's reaction varied, with a 3.48% drop after the last report. Shares are currently trading at $98.25, up 22.22% over the last 52 weeks, indicating a bullish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

CSWC

Capital Southwest (NASDAQ:CSWC) is expected to release its quarterly earnings report on Monday, 2024-01-29, with analysts predicting an EPS of $0.66. Investors are looking for an earnings beat and positive guidance for future growth. Historically, CSWC has surpassed EPS estimates, leading to share price increases. The stock has risen 31.71% over the past 52 weeks and was trading at $24.81 as of January 25.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:01 pm

IDYA

IDEAYA Biosciences (NASDAQ:IDYA) has received mixed analyst ratings over the last quarter, with 3 bullish and 5 somewhat bullish ratings. The average 12-month price target for IDYA is $44.5, with a high of $53.00 and a low of $36.00, representing a 16.49% increase from the previous average of $38.20. Analysts from firms including Goldman Sachs, RBC Capital, JP Morgan, Wedbush, and Guggenheim have updated their ratings and price targets. IDEAYA Biosciences is an oncology-focused precision medicine company with a negative revenue trend of -72.94% over 3 months and a high net margin of -341.38%. The company has a strong ROE of -5.44% and ROA of -5.17%, with no debt (debt-to-equity ratio of 0.0).

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:00 pm

BMRC

Bank of Marin (NASDAQ:BMRC) is scheduled to release its quarterly earnings report on Monday, 2024-01-29, with analysts expecting an EPS of $0.32. Historical data shows that the company's stock price tends to drop following earnings reports, even when EPS beats estimates. Over the last year, BMRC shares have declined by nearly 30%, indicating a bearish sentiment among long-term shareholders.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 3:00 pm